Human medicines European public assessment report (EPAR): Veltassa, patiromer, Date of authorisation: 19/07/2017, Revision: 9, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Improvac, Gonadotropin releasing factor (GnRF) analogue-protein conjugate, Status: Authorised
Referral: Micrazym and associated names, porcine pancreas enzymes Article 29(4) referrals European Commission final decision, 21/03/2024, 16/05/2024, 11/06/2024
Veterinary medicines European public assessment report (EPAR): Respivac TRT, Turkey rhinotracheitis virus, strain 1062, live, Status: Authorised
Agenda of the PRAC meeting 10-13 June 2024
Questions and answers relating to Grant Procedure no. EMA/GRANT/2024/02/IA - Medicines regulatory systems strengthening in Sub-Saharan Africa
Information on the Member States requirement for the nomination of a pharmacovigilance (PhV) contact person at national level
Final Minutes – HMA-EMA joint Big Data Steering Group teleconference - 22 April 2024
Human medicines European public assessment report (EPAR): Intuniv, guanfacine, Date of authorisation: 17/09/2015, Revision: 13, Status: Authorised
Questions and Answers on the tailored scientific advice to support step-by-step development of new biosimilars